Mangrove Partners »

Monte Rosa Therapeutics shares owned by Mangrove Partners

Quarter-by-quarter ownership of Monte Rosa Therapeutics (GLUE) shares owned by Mangrove Partners from 13F filings

Historical chart of Mangrove Partners investment in Monte Rosa Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Monte Rosa Therapeutics held by Mangrove Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Monte Rosa Therapeutics by Mangrove Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $226k 14k 16.45

More positions owned by Mangrove Partners

Indivior Pharmaceuticals (INDV)
Atmus Filtration Technologies Ord (ATMU)
Grayscale Ethereum Staking Shs New (ETH)
Rex American Resources (REX)
PG&E Corporation (PCG)
Oneok (OKE)
Millicom Intl Cellular S A Com Stk (TIGO)
Enova Intl (ENVA)
Millrose Pptys Com Cl A (MRP)
Keurig Dr Pepper (KDP)
Union Pacific Corporation (UNP)
Bio Rad Labs Cl A (BIO)
Flywire Corporation Com Vtg (FLYW)
Genuine Parts Company (GPC)
Bill Com Holdings Ord (BILL)

View all positions for Mangrove Partners

Top funds holding Monte Rosa Therapeutics

NEA Management Company
BlackRock
TCG Crossover Management
BVF
Baker Bros. Advisors
Suvretta Capital Management
Vestal Point Capital
State Street Corporation
Braidwell
Versant Venture Management
Vanguard Capital Management
American Century Companies
Silverarc Capital Management
Aisling Capital Management
Geode Capital Management

View all funds holding Monte Rosa Therapeutics